Federation Des Caisses Desjardins Du Quebec Amgen Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

$17.5 Billion
Q2 2024

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Amgen Inc stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 18,373 shares of AMGN stock, worth $5.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

18,373

Previous 18,662 1.55%

Holding current value

$5.8 Million

Previous $5.34 Billion 99.89%

% of portfolio

0.03%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $75,934 - $92,280	-289 Reduced 1.55%	18,373 $5.74 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $5.02 Million - $6.06 Million	18,662 New	18,662 $5.34 Billion
Q4 2023 Aug 14, 2024	SELL	$255.7 - $288.46 $1.14 Million - $1.28 Million	-4,443 Reduced 22.93%	14,935 $4.3 Billion
Q3 2023 Aug 14, 2024	SELL	$218.65 - $271.46 $509,673 - $632,773	-2,331 Reduced 10.74%	19,378 $5.21 Billion
Q2 2023 Aug 14, 2024	BUY	$214.27 - $253.37 $1.3 Million - $1.54 Million	6,089 Added 38.98%	21,709 $4.82 Billion
Q1 2023 Aug 14, 2024	BUY	$225.79 - $275.2 $1.87 Million - $2.28 Million	8,279 Added 112.78%	15,620 $3.78 Billion
Q4 2022 Aug 14, 2024	SELL	$229.03 - $291.01 $2.14 Million - $2.72 Million	-9,346 Reduced 56.01%	7,341 $1.93 Billion
Q3 2022 Aug 14, 2024	BUY	$224.46 - $253.15 $282,595 - $318,715	1,259 Added 8.16%	16,687 $3.76 Billion
Q2 2022 Aug 14, 2024	BUY	$230.71 - $256.74 $379,517 - $422,337	1,645 Added 11.93%	15,428 $3.75 Billion
Q1 2022 Aug 14, 2024	SELL	$219.27 - $242.57 $1.01 Million - $1.11 Million	-4,590 Reduced 24.98%	13,783 $3.33 Billion
Q4 2021 Aug 30, 2024	BUY	$198.88 - $227.6 $608,572 - $696,456	3,060 Added 12.62%	27,312 $6.14 Billion
Q3 2021 Aug 30, 2024	SELL	$212.27 - $248.7 $734,454 - $860,502	-3,460 Reduced 12.49%	24,252 $5.16 Billion
Q2 2021 Aug 30, 2024	BUY	$233.58 - $259.14 $2.18 Million - $2.42 Million	9,339 Added 50.83%	27,712 $6.75 Billion
Q1 2021 Aug 30, 2024	BUY	$221.91 - $258.6 $2.46 Million - $2.87 Million	11,092 Added 72.8%	26,329 $6.55 Billion
Q4 2020 Aug 30, 2024	BUY	$216.38 - $257.67 $2.28 Million - $2.71 Million	10,535 Added 224.05%	15,237 $3.5 Billion
Q3 2020 Aug 30, 2024	BUY	$234.65 - $260.95 $39,655 - $44,100	169 Added 3.73%	4,702 $1.2 Billion
Q2 2020 Aug 30, 2024	SELL	$197.81 - $242.74 $557,626 - $684,284	-2,819 Reduced 38.34%	4,533 $1.07 Billion
Q1 2020 Aug 30, 2024	SELL	$182.24 - $241.7 $3.27 Million - $4.34 Million	-17,947 Reduced 70.94%	7,352 $1.49 Billion
Q4 2019 Aug 30, 2024	BUY	$189.21 - $243.2 $843,687 - $1.08 Million	4,459 Added 21.4%	25,299 $6.1 Billion
Q3 2019 Aug 30, 2024	BUY	$174.11 - $208.62 $59,893 - $71,765	344 Added 1.68%	20,840 $4.03 Billion
Q2 2019 Aug 30, 2024	BUY	$166.7 - $195.41 $173,368 - $203,226	1,040 Added 5.35%	20,496 $3.78 Billion
Q1 2019 Aug 30, 2024	SELL	$180.87 - $203.88 $76,146 - $85,833	-421 Reduced 2.12%	19,456 $3.7 Billion
Q4 2018 Aug 30, 2024	BUY	$178.4 - $208.25 $268,313 - $313,208	1,504 Added 8.19%	19,877 $3.87 Billion
Q3 2018 Aug 30, 2024	BUY	$185.29 - $208.89 $10,932 - $12,324	59 Added 0.3%	19,897 $4.12 Billion
Q2 2018 Aug 30, 2024	SELL	$166.05 - $186.51 $681,635 - $765,623	-4,105 Reduced 17.14%	19,838 $3.66 Billion
Q1 2018 Aug 30, 2024	SELL	$169.43 - $198.0 $361,733 - $422,730	-2,135 Reduced 8.19%	23,943 $4.08 Billion
Q4 2017 Aug 30, 2024	SELL	$168.79 - $188.59 $1.18 Million - $1.31 Million	-6,964 Reduced 21.08%	26,078 $4.53 Billion
Q3 2017 Aug 30, 2024	SELL	$167.29 - $191.0 $33,458 - $38,200	-200 Reduced 0.6%	33,042 $6.16 Billion
Q2 2017 Aug 30, 2024	BUY	N/A	7,009 Added 26.72%	33,242 $5.73 Billion
Q1 2017 Aug 30, 2024	BUY	N/A	7,860	26,233 $4.3 Billion

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Amgen Inc Transaction History